Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Beginning Cash Balance (2022 - 2023)

Bioregenx's Beginning Cash Balance history spans 2 years, with the latest figure at $190891.0 for Q4 2023.

  • Quarterly results put Beginning Cash Balance at $190891.0 for Q4 2023, up 27170.14% from a year ago — trailing twelve months through Mar 2024 was $18001.0 (down 37.86% YoY), and the annual figure for FY2023 was $191001.0, up 27185.86%.
  • Beginning Cash Balance for Q4 2023 was $190891.0 at Bioregenx, up from -$172890.0 in the prior quarter.
  • In the past five years, Beginning Cash Balance ranged from a high of $190891.0 in Q4 2023 to a low of -$172890.0 in Q2 2023.